| Similar Articles |
|---|
 |
Bio-IT World
June 2006
Mark D. Uehling |
Afferenz on EDC, Images, and Data Integration There are people who think the outsourcing of IT to India will not affect the life sciences. But companies like Afferenz raises concerns about U.S. companies lagging behind Indian companies on laying the foundation for clinical trials.   |
Bio-IT World
March 17, 2004
Kenneth Getz |
Getting Past No Low adoption rates of e-clinical trial technology can't be blamed on external market dynamics alone. Biopharmas must face four inhibitors within their own organizations |
Bio-IT World
April 2006
Michelle Zubatch |
Value of Hosted Clinical Data Environments Instead of burning through venture capital, different levels of hosted clinical data management systems environments are available from clinical consulting vendors for efficiency-conscious clinical firms. |
Bio-IT World
August 2005
Ellen H. Julian |
Tech Expertise Singles Out Outsourcers Biopharmaceutical companies are flocking to consultants, outsourcers, and staffing firms to help with discrete clinical trial processes to gain access to advanced technologies and reduce the drain on already-scarce IT resources. |
Information Today
December 10, 2012 |
Thomson Reuters Announces Cortellis for Clinical Trials Intelligence Scheduled for release in early 2013, this capability will provide drug development and clinical professionals with the critical information. |
Bio-IT World
July 2005
Mark D. Uehling |
'E-source' Is Coming, Experts Say The odd marriages of the ancient and modern in clinical technologies were in evidence at the E-Clinical Trials & Research conference program. There was evidence of the adoption of advanced and robust commercial software -- even toward clinical trials that do not use paper, though most do. |
Bio-IT World
May 9, 2003
Mark D. Uehling |
Data Rapture? Electronic capture of data: Some say it unclogs the medieval clinical trials process. Others remain skeptical of software and put their trust in paper. |
Pharmaceutical Executive
September 1, 2008
Melanie North |
Publish or Perish FDAAA means that companies need to register clinical trials; and not only for publication planning. |
Bio-IT World
March 10, 2003
Spink & Blumenstiel |
Getting IT Right Applying information technology to trials can boost productivity. Here's a strategic framework for going e-clinical. |
Bio-IT World
April 16, 2004
Joel Hoffman |
Taking the Trial Out of Clinical Outsourcing Make sure the vendor's standard operating procedures will mesh with your own, and then tirelessly work toward systems integration. |
Wall Street & Technology
August 27, 2004
Jim Middlemiss |
The ABCs of ASPs The application-service-provider model is gaining momentum as firms seek ways to lower the cost of technology adoption. |
CFO
June 16, 2003
John Verity |
Down but Not Out There may be a second act for ASPs, who say they've figured out how to make software services work. |
Pharmaceutical Executive
November 1, 2006 |
Unraveling the eSource Industry-wide standards for electronic patient data have long felt like buried treasure. Companies today are getting closer - by way of a tangled map. |
Chemistry World
November 12, 2013
Dinsa Sachan |
Rough patch for India's clinical trial industry The Indian clinical trial industry is beset by uncertainty. Campaigners have petitioned the courts claiming that drug companies are exploiting poor people and this has led to more than 100 trials being put on hold. |
Bio-IT World
March 17, 2004 |
Speeding EDC Adoption Implementation by clinical sites is lumbering along at an unimpressive rate. Here's what must be done to speed things up |
The Motley Fool
March 29, 2010
Brian Orelli |
Look for Companies That Strike First Head-to-head trials, whether they're run by companies or by third parties, can be scary. But the way to make big money is by selling drugs that offer superior benefits, so investors should welcome the onslaught of upcoming comparative trial data. |
Bio-IT World
August 13, 2002
Mark D. Uehling |
Clinical Trial Data Management: Tortured by Paper Reams of paper stuffed into boxes and shipped to the FDA by the truckload is hardly the best approach to drug approval. But what's the right way? |
Pharmaceutical Executive
November 1, 2012
Sue Barrowcliffe |
Real World Insights Commercial teams as well as patients can benefit from managed access programs, which are designed to provide access to medicines outside of the clinical and commercial setting, for patients who have no other available treatment options. |
Bio-IT World
February 18, 2004 |
Correspondence One of the Top Three Worst Ideas... Bioinformatics: Reasons to Believe... |
PC Magazine
November 25, 2003 |
The At-Your-Service ASP Let someone else run your enterprise software while you do more important things. |
CIO
November 15, 2000
Christopher Koch |
Boy, That Was Fast! After Pandesic's failure last summer, that sound you hear is the popping of the ASP bubble... |
Bio-IT World
May 7, 2002
Malorye Branca |
In Silico Survivors Facing desperate times, bioinformatics companies revamp, refocus, or perish. |
Bio-IT World
December 15, 2003
Henry & Vertinsky |
The Hidden Costs of 'Free' Software Open-source software may be gaining ground in academic and government circles, but biotech users need to be aware of licensing pitfalls. |
Bio-IT World
January 21, 2005 |
How IT Can Decrease Time-to-Market in Clinical Trials Pharma manufacturers can learn from their industrial counterparts: Integrating systems can accelerate product delivery. |
Bio-IT World
November 2006
Mark D. Uehling |
Putting EDC on the Fast Track There's no escaping the imposing numbers of choices in launching a clinical trial using electronic data capture. Is there a better way? Clinical trial consultant Fast Track Systems says it has one. |
CIO
May 1, 2003
Meridith Levinson |
ASPs: The Next Chapter Application service providers are increasingly viewed as a viable option in the CRM space, particularly for small and midsize companies. |
Information Today
July 2, 2013 |
Thomson Reuters Offers Clinical Trial Intelligence Solutions These solutions improve clinical trials, speed up product development and release, and help professionals strengthen portfolios and R&D strategy. |
AskMen.com
Richard Stevens |
Participating In Clinical Trials Check out what participating in clinical trials involves and how you can join a study. You may even make some cash in the process. |
Pharmaceutical Executive
October 1, 2008
RS Kumar |
Evolving Clinical Trials Clinical trials need to change. A recent survey shows that industry should address the research supply chain for the greatest gains in efficiency. |
Chemistry World
October 15, 2013
Dinsa Sachan |
Supreme court ruling brings clinical trials to a halt in India The fate of 162 global clinical trials hangs in the balance, as the top Indian court has asked the government to provide more details on their approval process before they can proceed. |
Bio-IT World
November 12, 2002
James Golden |
The Business of Bioinformatics The industry has reached an interesting crossroads. As an academic branch of learning, bioinformatics remains mostly what it always was, a cross-disciplinary endeavor between computer science and molecular biology. But bioinformatics as a money-making proposition has different criteria for success. |
Chemistry World
January 25, 2013
Rajesh Parishwad |
Indian supreme court's anger over unregulated clinical trials The fledgling clinical trials industry in India has been hit by recent revelations of a lack of regulation. Now, the country's supreme court has criticized the body that oversees clinical trials for its inaction in the face of these unethical practices. |
Salon.com
February 26, 2002
Annalee Newitz |
Genome liberation The information that details who we are is too important to be privately owned... |
PC World
August 6, 2001
Frank Thorsberg |
McAfee.com Heralds Patent for Web Services Site hints it could quash competitors in court, but ASP consortium isn't worried... |
CIO
October 15, 2001
Stephanie Overby |
Drug Companies on speed The marriage of IT and medical research may be just what traditional pharmaceutical companies need to survive in an increasingly competitive field. Learn how IT is bringing the pharmaceutical industry into the information age... |
Bio-IT World
March 10, 2003
Michael Greeley |
Too Much Informatics Did bioinformatics companies forget about the fundamental law of supply and demand? |
CIO
October 15, 2000 |
The Same Old Mouse Trap? What we learn from history is that people never learn anything from history. All the hype over ASPs obscures the fact that they are basically service bureaus, an idea that hasn't been new since the 1960s, and is likely not to work as well now as it did then... |
Inc.
September 15, 2000
Ilan Mochari |
Making the Switch to the ASP Game When a high-tech trend threatened the future of his business, Michael Edell radically reshaped his company. Two years later, he's suffered record losses and lost legions of employees. But don't stop him now... |
InternetNews
April 23, 2004
Miller & Joyce |
Wall Street Shifting to On-Demand Model Merrill Lynch's On-Demand Index signals investors are getting ready for pay-as-you-go (i.e. application service provider) software companies -- or at least learning how to value them as stocks. |
Chemistry World
February 26, 2014 |
Out on a LIM Data management systems are widely used in certain sectors of science and industry, but how do different systems compare? |
CRM
June 2, 2003
Martin Schneider |
Hosts With the Most (Partners, That Is) ASP partnerships are aimed at giving customers robust CRM at a low price point. But are two vendors better than one? |
Bio-IT World
April 2007
Christopher Frenz |
The Case for Security in Bioinformatics Should developers or distributors of bioinformatics applications be required to make security considerations an essential element of their development or hosting process? While there have been no reports of widespread abuse of scientific computing resources to date, the potential does exist. |
